The Pharmacovigilance System Master File (PSMF) is a regulatory document that describes the pharmacovigilance system used by a marketing authorisation holder. It provides regulators with a structured overview of how pharmacovigilance activities are organised, governed, monitored and controlled throughout the organisation.
Introduction
The Pharmacovigilance System Master File (PSMF) is one of the most important documents within a pharmacovigilance system. Within the European Union, marketing authorisation holders (MAHs) are required to maintain a PSMF describing the pharmacovigilance system used to fulfil their legal obligations relating to the monitoring of medicinal product safety.
The PSMF is not merely an administrative requirement. It serves as the central description of how pharmacovigilance responsibilities are allocated, how safety information is managed, how oversight is maintained and how regulatory compliance is achieved. Regulatory authorities frequently review the document during inspections and assessments.
For Qualified Persons Responsible for Pharmacovigilance (QPPVs), familiarity with the PSMF is essential because it represents the documented framework of the pharmacovigilance system for which they maintain oversight.
Regulatory Basis
The requirement to maintain a PSMF arises from European pharmacovigilance legislation and is further detailed within Good Pharmacovigilance Practices (GVP) Module II.
The PSMF must be permanently and immediately available for inspection at the location where it is maintained. Regulators use the document to understand how pharmacovigilance obligations are fulfilled and how responsibilities are managed across the organisation.
Although organisations may structure the document differently, the information presented should allow regulators to understand the design, operation and governance of the pharmacovigilance system.
Purpose of the PSMF
The primary purpose of the PSMF is to provide a comprehensive description of the pharmacovigilance system.
Rather than requiring inspectors to review hundreds of procedures and records before understanding the organisation, the PSMF provides a consolidated overview of the system's structure and operation.
The document allows regulators to identify key responsibilities, governance arrangements, processes, systems, vendors and quality controls that support pharmacovigilance compliance.
What Information Does a PSMF Contain?
Although formats vary between organisations, most PSMFs contain information relating to the following areas:
- QPPV details and deputy arrangements
- Organisational structures and reporting lines
- Pharmacovigilance processes and responsibilities
- Computerised systems and databases
- Signal management activities
- Risk management processes
- Vendor and partner oversight arrangements
- Quality systems and compliance monitoring
- Performance metrics and governance mechanisms
- Annexes and inventories required by GVP Module II
Together, these sections provide a high-level but comprehensive picture of how pharmacovigilance activities are performed and controlled.
PSMF Versus SOPs
A common misconception is that the PSMF should contain detailed procedural instructions. In practice, the PSMF and Standard Operating Procedures (SOPs) serve different purposes.
The PSMF describes the pharmacovigilance system and its governance structure. SOPs describe how individual activities are performed.
For example, the PSMF may explain that literature monitoring activities are conducted under defined procedures and oversight arrangements. The operational details of literature searching, screening and review should be documented within SOPs rather than within the PSMF itself.
The Role of the QPPV
The QPPV is not necessarily the author or owner of the PSMF. However, regulators generally expect the QPPV to maintain awareness of the document's content, status and location.
The QPPV should understand how responsibilities are allocated, how outsourced activities are governed, how compliance risks are managed and how the pharmacovigilance system operates in practice.
Many organisations assign operational ownership of the PSMF to dedicated coordinators or quality functions, but the document remains closely linked to the QPPV's oversight responsibilities.
Inspection Perspective
The PSMF is frequently one of the first documents requested during a pharmacovigilance inspection.
Inspectors often review the document before arriving on site and use it to identify areas requiring further assessment. Organisational structures, outsourcing arrangements, computerised systems and governance mechanisms described within the PSMF frequently influence inspection planning.
Consistency between the PSMF and operational reality is critically important. If the document does not accurately reflect the pharmacovigilance system, inspectors may question the effectiveness of system oversight and change management processes.
Common Inspection Findings
Many PSMF-related inspection findings involve maintenance failures rather than deliberate non-compliance.
Examples include:
- Outdated organisational charts
- Incorrect QPPV or deputy information
- Missing vendor information
- Incomplete annexes and inventories
- Failure to reflect organisational changes
- Inaccurate descriptions of systems and processes
- Inconsistencies between procedures and the PSMF
These findings often indicate weaknesses in governance, change management or document review processes rather than isolated documentation errors.
Maintaining an Inspection-Ready PSMF
An effective PSMF should be maintained as a living document rather than updated only in preparation for inspections.
Organisations commonly establish formal review processes, change-control mechanisms and periodic quality assessments to ensure that the document remains accurate and current.
Good practices include:
- Clearly defined ownership responsibilities
- Scheduled reviews and approval workflows
- Integration with organisational change management
- Routine quality checks
- Inspection readiness assessments
- Version control and document governance procedures
The objective is not simply document maintenance but confidence that the document accurately represents the pharmacovigilance system at any point in time.
Frequently Asked Questions
Is a PSMF mandatory?
Within the European Union, marketing authorisation holders are generally required to maintain a PSMF describing their pharmacovigilance system.
How often should a PSMF be updated?
The PSMF should be updated whenever significant changes occur within the pharmacovigilance system and reviewed regularly to ensure ongoing accuracy.
Does the QPPV own the PSMF?
The QPPV is expected to maintain awareness of the PSMF and the system it describes. Operational ownership may reside with another function depending on organisational arrangements.
Is the PSMF reviewed during inspections?
Yes. The PSMF is routinely reviewed during pharmacovigilance inspections and often forms the basis for inspection planning and questioning.
Related Guides
References
- EMA Good Pharmacovigilance Practices (GVP) Module II – Pharmacovigilance System Master File.
- Directive 2001/83/EC, as amended.
- Regulation (EC) No 726/2004, as amended.
- European Medicines Agency pharmacovigilance inspection guidance.
- MHRA Good Pharmacovigilance Practices guidance.
Last reviewed: June 2026